Challenges in congenital heart disease in the Amazon region countries: A scoping review

Sophia Livas de Morais Almeida1, Andreza Dos Santos Laranjeira da Cunha1, Renata de Castro Silva1

  • 1Postgraduate Program in Health Sciences, Medical School, Federal University of Amazonas, Manaus, AM, Brazil.

PubMed

Insights

Congenital heart diseases (CHDs) present significant challenges in the Amazon region, with limited studies highlighting infrastructure and team deficits. Initiatives are underway to improve diagnosis and treatment for CHDs in this area.

Area of Science:

  • Cardiology
  • Public Health
  • Health Systems Research

Background:

  • Congenital heart diseases (CHDs) pose a significant public health concern globally.
  • The Amazon region faces unique challenges in healthcare delivery due to its vastness and resource limitations.

Purpose of the Study:

  • To systematically analyze and describe the primary challenges associated with congenital heart diseases (CHDs) in Amazonian countries.
  • To identify gaps in research and healthcare infrastructure for CHD management in the region.

Main Methods:

  • A systematic scoping review was conducted using PRISMA-ScR guidelines.
  • Searches were performed across Medline, Embase, Lilacs, and Google Scholar databases.
  • Inclusion criteria focused on articles addressing CHD in the Amazon region, excluding non-peer-reviewed materials.

Main Results:

  • Nine studies met the inclusion criteria, predominantly from Colombia and Brazil, published within the last decade.
  • Methodologies included cross-sectional and ecological designs, examining regional factors, diagnostic/treatment challenges, and multidisciplinary team issues.
  • Studies by surgeons provided more data on healthcare system challenges, including the impact of the COVID-19 pandemic.

Conclusions:

  • There is a growing but limited body of research on CHD in the Amazon region, primarily consisting of ecological and cross-sectional studies.
  • A significant lack of hospital infrastructure and multidisciplinary teams hinders effective CHD diagnosis and treatment.
  • Specialists in Colombia and Brazil are pursuing international training and aid to enhance the healthcare system for CHD patients.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
150
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3